Health Canada inspection
Takeda Pharmaceuticals America Inc: Health Canada inspection of Jan 22, 2021
Health Canada · GVP · rating C
Key facts
| Establishment | Takeda Pharmaceuticals America Inc |
|---|---|
| City | Lexington |
| Province | MA |
| Country | United States |
| Program | GVP |
| Start date | Jan 8, 2021 |
| End date | Jan 22, 2021 |
| Rating | C |
| Rating description | Compliant |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: